pindolol has been researched along with Myocardial Infarction in 53 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lorcainide, a new class I antiarrhythmic agent, was administered intravenously to eight patients with acute myocardial infarction for 24 hours, and thereafter given by mouth, 200 mg daily for ten days." | 9.05 | Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction. ( Gordin, A; Heikkilä, J; Leinonen, H; Sundberg, S, 1984) |
| "The effect of oral pindolol 15 mg daily was compared with placebo in 529 patients who had electrical and/or mechanical complications after an acute myocardial infarction." | 9.05 | The effect of pindolol on the two years mortality after complicated myocardial infarction. ( , 1983) |
| "Pindolol, a beta blocker with intrinsic sympathomimetic activity, was investigated in a randomised controlled trial of 100 patients presenting within 12 hours of uncomplicated acute myocardial infarction." | 9.05 | Failure of intravenous pindolol to reduce the hemodynamic determinants of myocardial oxygen demand or enzymatically determined infarct size in acute myocardial infarction. ( O'Rourke, MF; Owensby, DA, 1985) |
| "This study investigated the effects of myocardial infarction (MI)-induced cardiac failure and treatment with an angiotensin-converting enzyme (ACE) inhibitor perindopril (2 mg/kg/day) on rat beta-adrenoceptor (beta-ar) subtypes in anatomically defined regions of infarcted left ventricular (LV) free wall and noninfarcted tissue from right ventricle (RV) by using autoradiography." | 7.70 | Regulation of beta-adrenoceptors in a rat model of cardiac failure: effect of perindopril. ( Gu, XH; Kompa, AR; Summers, RJ, 1998) |
| "The effect of pindolol on experimental myocardial infarction was studied in a pig model." | 7.67 | Effects of pindolol therapy on the size of experimentally induced myocardial infarction in the pig. ( Althaus, U; Friedli, HP; Gurtner, HP; Magnenat, L, 1986) |
| "The study was designed to assess the antiarrhythmic and antianginal properties of pindolol as well as the tolerance to the drug by patients who had experienced a myocardial infarction 5 to 6 months previously." | 7.66 | Pindolol postmyocardial infarction study: evaluation of the drug's antiarrhythmic and antianginal activity. ( Roskamm, N; Samek, L; Sturzenhofecker, P; Welzel, D, 1982) |
| "A study was designed to examine ventricular arrhythmias in the acute phase of experimental myocardial infarction in the pig and to evaluate possible antiarrhythmogenic influence of the beta-adrenergic blocking drug pindolol (Visken) and the calcium antagonist Ro 11-1781." | 7.66 | [Ventricular arrhythmias in the acute stage of experimental swine myocardial infarct; effect of the beta blocker pindolol and the calcium antagonist Ro 11-1781]. ( Althaus, U; Dolder, M; Frank, J; Gertsch, M; Gurtner, HP, 1978) |
| "Seven patients with acute anterior myocardial infarction were treated with a betablocker (Pindolol 0." | 7.65 | [Reduction of myocardial ischemia by betablocker (Pindolol) in patients with acute infarction (author's transl)]. ( Harmjanz, D; Heidrich-Meisner, G, 1977) |
| "Pindolol was administered orally (5 mg 8th-hourly) to 30 patients 5--19 (mean = 9." | 5.26 | Oral pindolol in acute evolving myocardial infarction. ( Baron, D; Le Cheminant, D; O'Rourke, MF; Sammel, N; Washington, H, 1979) |
| "The relevance of the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds to the clinical therapeutics of acute myocardial infarction was evaluated in 20 patients with an uncomplicated acute myocardial infarction by comparing the haemodynamic effects of equivalent beta-blocking doses of propranolol (non-cardioselective; no ISA) and pindolol (non-cardioselective; 50% ISA)." | 5.05 | Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction? ( Ahuja, RC; Hafizullah, M; Hussain, M; Nelson, GI; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "Lorcainide, a new class I antiarrhythmic agent, was administered intravenously to eight patients with acute myocardial infarction for 24 hours, and thereafter given by mouth, 200 mg daily for ten days." | 5.05 | Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction. ( Gordin, A; Heikkilä, J; Leinonen, H; Sundberg, S, 1984) |
| "The effect of oral pindolol 15 mg daily was compared with placebo in 529 patients who had electrical and/or mechanical complications after an acute myocardial infarction." | 5.05 | The effect of pindolol on the two years mortality after complicated myocardial infarction. ( , 1983) |
| "Pindolol, a beta blocker with intrinsic sympathomimetic activity, was investigated in a randomised controlled trial of 100 patients presenting within 12 hours of uncomplicated acute myocardial infarction." | 5.05 | Failure of intravenous pindolol to reduce the hemodynamic determinants of myocardial oxygen demand or enzymatically determined infarct size in acute myocardial infarction. ( O'Rourke, MF; Owensby, DA, 1985) |
| "Two grams of methylprednisolone was administratered to ten patients with acute myocardial infarction at an average of 13 hours from the onset of symptoms; pain in the chest was not relieved in six of the ten patients." | 5.04 | Failure of methylprednisolone to protect acutely ischemic myocardium: a contrast with subsequent beta-adrenergic blockade in man. ( Heikkilä, J; Nieminen, MS, 1978) |
| "This study investigated the effects of myocardial infarction (MI)-induced cardiac failure and treatment with an angiotensin-converting enzyme (ACE) inhibitor perindopril (2 mg/kg/day) on rat beta-adrenoceptor (beta-ar) subtypes in anatomically defined regions of infarcted left ventricular (LV) free wall and noninfarcted tissue from right ventricle (RV) by using autoradiography." | 3.70 | Regulation of beta-adrenoceptors in a rat model of cardiac failure: effect of perindopril. ( Gu, XH; Kompa, AR; Summers, RJ, 1998) |
| "The effect of pindolol on experimental myocardial infarction was studied in a pig model." | 3.67 | Effects of pindolol therapy on the size of experimentally induced myocardial infarction in the pig. ( Althaus, U; Friedli, HP; Gurtner, HP; Magnenat, L, 1986) |
| "Combination of the beta-adrenergic blocking agent visken with glucagon in the acute period of myocardial infarction possesses higher antiarrhythmic activity with a negligible cardiodepressive effect as compared to that of isolated administration of visken and leads to a decrease in the excessive production of catecholamines and glucocorticoids in the blood." | 3.66 | [Anti-arrhythmic and hemodynamic effects of visken and glucagon in rhythm disorders in the acute phase of myocardial infarct]. ( Golikov, AP; Ivleva, VI; Orlov, AI; Stepura, OB, 1980) |
| " Lidocaine and pindolol pretreatment increased the survival rate and attenuated the life-threatening arrhythmias during the first 20 min, but did not influence the infarct size 16 hrs later." | 3.66 | Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. ( Koltai, M; Leprán, I; Siegmund, W; Szekeres, L, 1983) |
| " Thirty-six subjects (healthy, severe angina pectoris, or acute myocardial infarction) were studied 15 minutes either after the beta 1-selective beta-blocking drug metoprolol had been administered in total doses of 2 and 10 mg intravenously or after pindolol, a beta blocker with intrinsic sympathomimetic activity (ISA), in total doses of 0." | 3.66 | Cardiac safety of acute beta blockade: intrinsic sympathomimetic activity is superior to beta-1 selectivity. ( Heikkilä, J; Nieminen, MS, 1982) |
| "The study was designed to assess the antiarrhythmic and antianginal properties of pindolol as well as the tolerance to the drug by patients who had experienced a myocardial infarction 5 to 6 months previously." | 3.66 | Pindolol postmyocardial infarction study: evaluation of the drug's antiarrhythmic and antianginal activity. ( Roskamm, N; Samek, L; Sturzenhofecker, P; Welzel, D, 1982) |
| "A study was designed to examine ventricular arrhythmias in the acute phase of experimental myocardial infarction in the pig and to evaluate possible antiarrhythmogenic influence of the beta-adrenergic blocking drug pindolol (Visken) and the calcium antagonist Ro 11-1781." | 3.66 | [Ventricular arrhythmias in the acute stage of experimental swine myocardial infarct; effect of the beta blocker pindolol and the calcium antagonist Ro 11-1781]. ( Althaus, U; Dolder, M; Frank, J; Gertsch, M; Gurtner, HP, 1978) |
| "Seven patients with acute anterior myocardial infarction were treated with a betablocker (Pindolol 0." | 3.65 | [Reduction of myocardial ischemia by betablocker (Pindolol) in patients with acute infarction (author's transl)]. ( Harmjanz, D; Heidrich-Meisner, G, 1977) |
| "After acute circumscribed myocardial infarction the effects of the beta-sympatholytic agent 1-(indol-4-yl-oxy)-3-isopropyl-amino-propan-2-ol (pindolol; Visken) on hemodynamics and contractility were examined." | 3.65 | [Acute myocardial infarct and pindolol. Effect of a beta sympatholytic with intrinsic sympathomimetic activity on hemodynamics and contractility]. ( Abendroth, RR; Hübner, H; Meesmann, W; Stephan, K, 1976) |
| "Mepindolol-treated rats, however, showed a phospholipid concentration of 0." | 1.27 | [Mepindolol reduction of the degradation of phospholipids and the necrosis induced by myocardial ischemia]. ( Ambrosio, G; Cappelli Bigazzi, M; Chiariello, M; Pellegrino, A; Perrone Filardi, P; Vallone, C, 1985) |
| "Pindolol was administered orally (5 mg 8th-hourly) to 30 patients 5--19 (mean = 9." | 1.26 | Oral pindolol in acute evolving myocardial infarction. ( Baron, D; Le Cheminant, D; O'Rourke, MF; Sammel, N; Washington, H, 1979) |
| "In 5 cases a favourable effect on extrasystoles and in 2 cases on sinus tachycardia were observed." | 1.26 | [Hemodynamics after prindolol and digitalis in acute myocardial infarction (author's transl)]. ( Bachour, G; Bender, F; Hochrein, H, 1976) |
| "Pindolol was given 30 min prior to the ligation of the left anterior descending coronary artery and on the following 5 days twice daily in a dosage of 0." | 1.26 | [Effect of pindolol (Visken) on the size and hemodynamics of the exerimental myocardial infarct in the pig]. ( Althaus, U; Dolder, M; Gurtner, HP; Kohler, B; Seeberger, B; Zimmermann, W, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 50 (94.34) | 18.7374 |
| 1990's | 3 (5.66) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golikov, AP | 3 |
| Orlov, AI | 3 |
| Ivleva, VI | 1 |
| Stepura, OB | 1 |
| Maĭorov, NI | 2 |
| Vaniev, SB | 2 |
| Berestov, AA | 1 |
| Heikkilä, J | 5 |
| Nieminen, MS | 5 |
| el-Assali, D | 1 |
| Cherevatov, BG | 1 |
| Boiarshin, SV | 1 |
| Tarnakin, AG | 1 |
| Frishman, WH | 2 |
| Furberg, CD | 2 |
| Friedewald, WT | 2 |
| Jackson, EA | 1 |
| Sullman, SA | 1 |
| Silke, B | 2 |
| Verma, SP | 2 |
| Ahuja, RC | 1 |
| Hussain, M | 1 |
| Hafizullah, M | 1 |
| Reynolds, G | 2 |
| Nelson, GI | 1 |
| Taylor, SH | 2 |
| Samek, L | 3 |
| Stürzenhofecker, P | 2 |
| Roskamm, H | 2 |
| Arita, M | 2 |
| Kiyosue, T | 1 |
| Leinonen, H | 1 |
| Sundberg, S | 1 |
| Gordin, A | 1 |
| Lange, R | 1 |
| Kloner, RA | 1 |
| Brandes, JW | 1 |
| Körst, HA | 1 |
| Littmann, KP | 1 |
| Leprán, I | 1 |
| Koltai, M | 1 |
| Siegmund, W | 1 |
| Szekeres, L | 2 |
| Welzel, D | 1 |
| Roskamm, N | 1 |
| Steinberg, SF | 1 |
| Zhang, H | 1 |
| Pak, E | 1 |
| Pagnotta, G | 1 |
| Boyden, PA | 1 |
| Hisatome, I | 1 |
| Gu, XH | 1 |
| Kompa, AR | 1 |
| Summers, RJ | 1 |
| Berdeaux, A | 1 |
| Peres da Costa, C | 1 |
| Garnier, M | 1 |
| Boissier, JR | 1 |
| Giudicelli, JF | 1 |
| O'Rourke, MF | 2 |
| Baron, D | 1 |
| Washington, H | 1 |
| Sammel, N | 1 |
| Le Cheminant, D | 1 |
| Zilcher, H | 1 |
| Glogar, D | 1 |
| Repetto, S | 1 |
| Cozzi, A | 1 |
| Forgione, N | 1 |
| Verna, E | 1 |
| Binaghi, G | 1 |
| Friedemann, M | 1 |
| Bachour, G | 2 |
| Hochrein, H | 2 |
| Bender, F | 2 |
| Hůla, J | 1 |
| Zikmund, M | 1 |
| Gabrielli, G | 1 |
| Salvi, W | 1 |
| Scambia, L | 1 |
| Fiorani, S | 1 |
| Frank, J | 1 |
| Dolder, M | 2 |
| Gertsch, M | 1 |
| Althaus, U | 3 |
| Gurtner, HP | 3 |
| Zetterquist, S | 1 |
| Furberg, C | 1 |
| Ringqvist, I | 1 |
| Söderholm, B | 1 |
| Schulte, D | 1 |
| Klepzig, H | 1 |
| Heidrich-Meisner, G | 1 |
| Harmjanz, D | 1 |
| Kobayashi, A | 1 |
| Sekiguchi, M | 1 |
| Aosaki, M | 1 |
| Nakamura, K | 1 |
| Ichihara, T | 1 |
| Kohler, B | 1 |
| Seeberger, B | 1 |
| Zimmermann, W | 1 |
| Hübner, H | 2 |
| Stephan, K | 2 |
| Meesmann, W | 2 |
| Abendroth, RR | 1 |
| Vleeming, W | 1 |
| van der Wouw, PA | 1 |
| te Biesebeek, JD | 1 |
| van Rooij, HH | 1 |
| Wemer, J | 1 |
| Porsius, AJ | 1 |
| Ambrosio, G | 1 |
| Cappelli Bigazzi, M | 1 |
| Perrone Filardi, P | 1 |
| Pellegrino, A | 1 |
| Vallone, C | 1 |
| Chiariello, M | 1 |
| Frais, MA | 1 |
| Sandrikov, VA | 1 |
| Iakovlev, VF | 1 |
| Seleznev, MN | 1 |
| Maglakelidze, TA | 1 |
| Friedli, HP | 1 |
| Magnenat, L | 1 |
| Owensby, DA | 1 |
| Mihail, A | 1 |
| Popescu, P | 1 |
| Ioan, A | 1 |
| Bruckner, I | 1 |
| Paraschiv, A | 1 |
| Petrescu, X | 1 |
| Popa, N | 1 |
| Singh, BN | 1 |
| Jewitt, DE | 1 |
| Delius, L | 1 |
| Lübke, KO | 1 |
| Bloch, A | 1 |
| Horvat, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for pindolol and Myocardial Infarction
| Article | Year |
|---|---|
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; | 1974 |
12 trials available for pindolol and Myocardial Infarction
| Article | Year |
|---|---|
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?
Topics: Adrenergic beta-Antagonists; Aged; Dose-Response Relationship, Drug; Hemodynamics; Humans; Injection | 1984 |
Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Clinical Tria | 1984 |
The effect of pindolol on the two years mortality after complicated myocardial infarction.
Topics: Aged; Digitalis Glycosides; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle A | 1983 |
Rapid monitoring of regional myocardial ischaemia with echocardiography and ST segment shifts in man. Modification of "infarct size" and hemodynamics by dopamine and beta blockade.
Topics: Acute Disease; Adult; Aged; Dopamine; Echocardiography; Female; Hemodynamics; Humans; Male; Middle A | 1978 |
Failure of methylprednisolone to protect acutely ischemic myocardium: a contrast with subsequent beta-adrenergic blockade in man.
Topics: Acute Disease; Aged; Cardiac Output; Clinical Trials as Topic; Coronary Disease; Female; Humans; Inj | 1978 |
Separate and combined effects of pindolol and isosorbide dinitrate in standardized exercise tests of patients with angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; E | 1975 |
Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Coronary Disease; Heart Rate; Hemodyna | 1986 |
Failure of intravenous pindolol to reduce the hemodynamic determinants of myocardial oxygen demand or enzymatically determined infarct size in acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Creatine Kinase; Female; Heart Rate; Hemodyna | 1985 |
[The efficiency of coronary therapy with Visken (pindolol). A combined clinical and experimental analysis (author's transl)].
Topics: Adult; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Electrocardiogra | 1974 |
[Effects of LBI45, practolol and a placebo on the exercise tests of coronary patients. A double-blind study (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Electroca | 1974 |
39 other studies available for pindolol and Myocardial Infarction
| Article | Year |
|---|---|
[Anti-arrhythmic and hemodynamic effects of visken and glucagon in rhythm disorders in the acute phase of myocardial infarct].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catecholamin | 1980 |
[Hemodynamic reactions to the use of beta-adrenoblockaders in acute myocardial infarct].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; | 1980 |
[Use of beta-adrenoblockaders in the therapy of the syndromes accompanying acute myocardial infarct].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiac Output; Hemodynamics; Humans | 1981 |
Acute myocardial infarction: selective or ISA-type beta-adrenoceptor blocking drug?
Topics: Adrenergic beta-Antagonists; Coronary Disease; Humans; Metoprolol; Myocardial Infarction; Pindolol; | 1982 |
[Changes in the echocardiographic indices in patients with acute myocardial infarct treated with viscen].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Echocardiography; Female; Humans; Male; Middle Aged; Myoca | 1983 |
[Pindolol in myocardial infarction patients: (author's transl)].
Topics: Cardiac Complexes, Premature; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Myocardial Infar | 1980 |
Modification of "depressed fast channel dependent slow conduction" by lidocaine and verapamil in the presence or absence of catecholamines--evidence for alteration of preferential ionic channels for slow conduction.
Topics: Action Potentials; Animals; Catecholamines; Guinea Pigs; Heart Conduction System; In Vitro Technique | 1983 |
Failure of pindolol and metoprolol to reduce the size of non-reperfused infarcts in dogs using area at risk techniques.
Topics: Animals; Coronary Circulation; Dogs; Hemodynamics; Metoprolol; Myocardial Infarction; Pindolol; Risk | 1984 |
Pindolol in the treatment of complicated myocardial infarction.
Topics: Humans; Myocardial Infarction; Pindolol; Research Design | 1984 |
[Myocardial infarct after sudden discontinuation of a beta blocker. Studies after discontinuation of treatment with the combination drug Viskenit].
Topics: Adult; Aged; Angina Pectoris; Drug Administration Schedule; Drug Combinations; Female; Humans; Isoso | 1980 |
Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Coronary Vessels; Disease Models, Animal; Lidocaine | 1983 |
Cardiac safety of acute beta blockade: intrinsic sympathomimetic activity is superior to beta-1 selectivity.
Topics: Adult; Aged; Angina Pectoris; Drug Evaluation; Echocardiography; Exercise Test; Female; Heart Ventri | 1982 |
Pindolol postmyocardial infarction study: evaluation of the drug's antiarrhythmic and antianginal activity.
Topics: Adult; Angina Pectoris; Arrhythmias, Cardiac; Drug Evaluation; Exercise Test; Heart Rate; Humans; Mi | 1982 |
Antianginal and antiarrhythmic effects of pindolol in post-infarct patients.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Heart Rate; Humans; Myocardial Infarction; Physical Exertion; | 1982 |
Characteristics of the beta-adrenergic receptor complex in the epicardial border zone of the 5-day infarcted canine heart.
Topics: Adenylyl Cyclases; Animals; Dogs; Female; GTP-Binding Proteins; Immunoblotting; Iodocyanopindolol; I | 1995 |
Effects of catecholamines on the residual sodium channel dependent slow conduction in guinea pig ventricular muscles under normoxia and hypoxia.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium Channels; Catecholamines; Dose-Response Re | 1995 |
Regulation of beta-adrenoceptors in a rat model of cardiac failure: effect of perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Blood Pressure; Body Weight; Dow | 1998 |
Beta adrenergic blockade, regional left ventricular blood flow and ST-segment elevation in canine experimental myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Dogs; Electrocardiography; Female; Hemod | 1978 |
Oral pindolol in acute evolving myocardial infarction.
Topics: Administration, Oral; Adult; Aged; Analgesics, Opioid; Blood Pressure; Female; Gastrointestinal Moti | 1979 |
[Non arrhythmogenic sudden death as complication of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, | 1979 |
[Beta-blocking therapy in the acute phase of myocardial infarct].
Topics: Acute Disease; Adrenergic beta-Antagonists; Humans; Myocardial Infarction; Pindolol | 1979 |
[Treatment of rhythm disorders following acute heart infarction using a beta receptor blockader (Visken)].
Topics: Blood Pressure; Cardiac Complexes, Premature; Central Venous Pressure; Heart Rate; Humans; Injection | 1975 |
[Proceedings: Use of prindolol in acute myocardial infarct with control of hemodynamics].
Topics: Cardiac Complexes, Premature; Digitalis Glycosides; Drug Antagonism; Hemodynamics; Humans; Myocardia | 1975 |
[Hemodynamics after prindolol and digitalis in acute myocardial infarction (author's transl)].
Topics: Acute Disease; Adult; Aged; Blood Pressure; Cardiac Complexes, Premature; Cardiac Output; Digitalis | 1976 |
[Effect of viskenit on the efficiency of the left ventricle in patients with post-infarction angina pectoris - echocardiographic study].
Topics: Angina Pectoris; Echocardiography; Heart Ventricles; Humans; Isosorbide Dinitrate; Male; Myocardial | 1979 |
[Critical evaluation of the use of beta-blocking agents in the treatment of acute myocardial infarct in intensive therapy and resuscitation].
Topics: Acute Disease; Coronary Care Units; Drug Evaluation; Humans; Myocardial Infarction; Pindolol | 1979 |
[Ventricular arrhythmias in the acute stage of experimental swine myocardial infarct; effect of the beta blocker pindolol and the calcium antagonist Ro 11-1781].
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Calcium; Female; Myocardial Infarction; Pindolol; Swin | 1978 |
[Cardiovascular collapse in a damaged heart following 10 mg of propranolol or 1,25 mg of pindolol].
Topics: Adult; Humans; Male; Myocardial Infarction; Pindolol; Propranolol; Syncope | 1977 |
[Reduction of myocardial ischemia by betablocker (Pindolol) in patients with acute infarction (author's transl)].
Topics: Acute Disease; Adult; Aged; Blood Pressure; Coronary Circulation; Electrocardiography; Heart Rate; H | 1977 |
[Large dose of pindolol as an effective treatment of intractable ventricular tachyarrhythmia complicating post myocardial infarctectomy. A case report (author's transl)].
Topics: Humans; Male; Middle Aged; Myocardial Infarction; Pindolol; Tachycardia | 1977 |
[Effect of pindolol (Visken) on the size and hemodynamics of the exerimental myocardial infarct in the pig].
Topics: Animals; Heart Ventricles; Hemodynamics; Myocardial Infarction; Pindolol; Swine | 1977 |
[Acute myocardial infarct and pindolol. Effect of a beta sympatholytic with intrinsic sympathomimetic activity on hemodynamics and contractility].
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Myocardial Contraction; Myocardial In | 1976 |
[Dose-related effect of the beta sympatholytic agent prindolol (Visken) on hemodynamics and contractility of the heart following experimental coronary occlusion].
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Myocardial Contraction; Myocardial In | 1975 |
Density of beta adrenoceptors in rat heart and lymphocytes 48 hours and 7 days after acute myocardial infarction.
Topics: Animals; Cell Membrane; Dobutamine; Heart; Heart Ventricles; Isoproterenol; Lymphocytes; Male; Myoca | 1989 |
[Mepindolol reduction of the degradation of phospholipids and the necrosis induced by myocardial ischemia].
Topics: Adrenergic beta-Antagonists; Animals; Creatine Kinase; Hemodynamics; Male; Myocardial Infarction; Ph | 1985 |
[Contractile function of the myocardium and central hemodynamics in acute myocardial infarct patients after a single intravenous injection of adrenergic beta receptor blockaders].
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Coronary Artery Bypass; Hemodynamics; Humans; Int | 1986 |
Cardioprotection by anti-ischaemic and cytoprotective drugs.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Death, Sudden; Dietary Fats; Epoprostenol; Humans; | 1987 |
Effects of pindolol therapy on the size of experimentally induced myocardial infarction in the pig.
Topics: Animals; Arrhythmias, Cardiac; Female; Hemodynamics; Myocardial Infarction; Pindolol; Swine | 1986 |
[On the treatment of angina pectoris with beta-blocking agents (Eraldin, Visken)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Angina Pectoris; Humans; Myocardial Infar | 1973 |